Literature DB >> 16262212

How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump?

Victor M Montori, Jason W Busse, Gaieta Permanyer-Miralda, Ignacio Ferreira, Gordon H Guyatt.   

Abstract

Mesh:

Year:  2005        PMID: 16262212

Source DB:  PubMed          Journal:  ACP J Club        ISSN: 1056-8751


× No keyword cloud information.
  5 in total

1.  Prevention of diabetes.

Authors:  Carl Heneghan; M Thompson; R Perera
Journal:  BMJ       Date:  2006-10-14

2.  Low-density lipoprotein cholesterol lowering in the prevention of CHD: how low should we go?

Authors:  William L Isley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

Review 3.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis.

Authors:  Karl Horvath; Klaus Koch; Klaus Jeitler; Eva Matyas; Ralf Bender; Hilda Bastian; Stefan Lange; Andrea Siebenhofer
Journal:  BMJ       Date:  2010-04-01

4.  Testing for heterogeneity among the components of a binary composite outcome in a clinical trial.

Authors:  Janice Pogue; Lehana Thabane; P J Devereaux; Salim Yusuf
Journal:  BMC Med Res Methodol       Date:  2010-06-07       Impact factor: 4.615

5.  Designing and analyzing clinical trials with composite outcomes: consideration of possible treatment differences between the individual outcomes.

Authors:  Janice Pogue; P J Devereaux; Lehana Thabane; Salim Yusuf
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.